Create an account or log in to participate in this activity
At the conclusion of this activity, participants should be better able to:
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact Hours: 1.00; of which 0.25 is eligible for pharmacology credit
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 0.75 contact hours (0.075 CEUS) for completing the requirements for CE. No partial credit is available. ACPE Universal Activity Number (UAN): 0060-9999-23-032-H08-P.
In order to successfully complete this activity, you are required to listen to both episodes of the podcast, and complete the posttest and evaluation. Credit will be awarded provided a score of 70% or better is achieved.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Daniel P. Alford, MD, MPH (CME Course Director)
Professor of Medicine
Associate Dean, Continuing Medical Education
Boston University Chobanian & Avedisian School of Medicine
Director, Clinical Addiction Research and Education (CARE) Unit
Boston Medical Center
Patrick Kelly, PharmD
University of Rhode Island College of Pharmacy
Catherine Abrams, BSN, RN
Clinical Research Nurse
School of Medicine, Department of Pediatrics, Division of Neurology
Faculty members have no relevant relationships to disclose. Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.
Ilana Hardesty, Senior Operations Manager, Boston University Chobanian & Avedisian School of Medicine CCE, has no relevant financial relationships to disclose.
Date of Release: February 15, 2023
Date of Expiration: February 14, 2024
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
SCOPE of Pain
© 2023 Trustees of Boston University. Site by Root802.